InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Ross Andrew L., 董事. Officer active across 1 company, notably iSpecimen Inc.. Aggregated, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €526. Activity tracked since 17 June 2021. The latest transaction was disclosed on 17 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Andrew L. Ross is a Director of iSpecimen Inc. In this role, he participates in the governance of the company and strategic decision-making. iSpecimen Inc. specializes in the collection and distribution of biological samples. Andrew brings valuable expertise in leadership and strategy.